Genetron
In Brief This Week: Bio-Rad, Roche, BioPorto, Thermo Fisher Scientific, Danaher, Agilent, More
News items for the week of Feb. 19, 2024.
360Dx Top 30 Continues Downward Slide, Falling 11 Percent in October
Of the companies in the index, 25 companies saw their share prices decline, while four saw their stock prices rise. One company's share price remained flat.
CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval
The test is used to detect human platelet-derived growth factor receptor alpha gene mutations in gastrointestinal stromal tumors.
Genetron Health Receives Nasdaq Noncompliance Notice
The Chinese cancer molecular profiling company has 180 calendar days, or until Nov. 13, to regain compliance with the Nasdaq minimum bid price requirement.
360Dx Top 30 Ends 2022 With 2 Percent Dip in December
Of the 30 companies in the index, nine saw their stock prices rise, while 21 firms' share prices decreased.
Aug 1, 2022
360Dx Top 30 Rebounds in July After June Swoon
Jul 1, 2022
360Dx Top 30 Drops 5 Percent in June
Jun 2, 2022
Genetron Health Q1 Revenues Up 20 percent
Mar 29, 2022
Genetron Health Q4 Revenues Up 10 Percent
Jan 4, 2022